Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 1479

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 9A
Chunk 1479
---
 such securities as a result of its Investment Management Agreement with Armistice Capital.

Change
of Control

The
Company is not aware of any arrangements which may at a subsequent date result in a change of control of the Company.

82

Securities
authorized for issuance under equity compensation plans 

2018
Equity Incentive Plan

Our
2018 Equity Incentive Plan (the “Plan”) provides for equity incentives to be granted to our employees, executive officers
or directors and to key advisers and consultants. Equity incentives may be in the form of stock options with an exercise price of not
less than the fair market value of the underlying shares as determined pursuant to the Plan, restricted stock awards, other stock- based
awards, or any combination of the foregoing. The Plan is administered by the Company’s compensation committee or, alternatively,
if there is no compensation committee, the Company’s board of directors. We have reserved 3,000,000 shares of our common stock
for issuance under the Plan, of which 1,187,189 shares have been granted under the Plan as of the date of this Annual Report, of which
1,084,644 remain subject to vesting.

The
following table provides information as of December 31, 2024 about our equity compensation plans and arrangements.

    Plan category 
    Number of securities to be issued upon exercise of outstanding options, warrants and rights  
    Weighted- average exercise price of outstanding options, warrants and rights  
    Number of securities remaining available for future issuance under equity compensation plans 
  
    Equity compensation plans approved by security holders 
     1,084,644  
    $0.84  
     1,231,910 
  
    Equity compensation plans not approved by security holders 
     –  
     –  
     – 
  
    Total 
     1,084,644  
     0.84  
     1,231,910 

*Outstanding
equity incentive grants consist entirely of restricted stock units which automatically vest over time into an equal number of shares
of common stock at no additional cost to the holder.

You
may find additional information regarding our equity compensation plans in Note 6 of the Notes to our Consolidated Financial Statements.

Item
13. Certain Relationships and Related Transactions, and Director Independence

Related
Party Transactions

Unless
described below, during the last two fiscal years, there were no transactions or series of similar transactions